PLAUR

Across TCGA pan-cancer cohorts, PLAUR Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated PLAUR data layer compared with 27 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher PLAUR Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PLAUR expression acts as an unfavorable survival marker.

THYM, LUAD, and BLCA are the cancer types where PLAUR Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
LUAD	OS	Median	All	0.068	0.812	<.001	36	view →
BLCA	OS	Median	IV	0.130	0.599	.002	9	view →
COAD	DFS	Median	II,III,IV	0.200	0.648	.019	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

PLAUR–THYM (OS)

Open the THYM breakdown →